It has reached the top

Junior Editorial Board

Junior Editorial Board Members

Bernhard Biersack

Organic Chemistry Laboratory, University of Bayreuth, Bayreuth, Germany.

Research Interests: medicinal chemistry, drug design, epigenetics, metal-based drugs, alkylating agents, tubulin-binding drugs, kinase inhibitors, HDAC inhibitors.

Ilana Chefetz

Hormel Institute, University of Minnesota, Austin, MN, USA.

Research Interests: ovarian cancer, cell death, necroptosis, cancer stem cells, chemoresistance, metabolism, DNA damage and repair, ovary and brain.

Hexin Chen

Department of Biological Sciences, University of South Carolina, Columbia, SC, USA.

Research Interests: breast cancer biology, caner stem cells, microRNA, HER2-targeted therapy, immune escape mechanism, immunotherapy.

Ivy Chung

Department of Pharmacology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.

Research Interests: cancer therapeutics, tumor microenvironment, cancer-associated fibroblasts, drug pharmacology, drug resistance.

Alessandra Ferraresi

Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.

Research Interests: autophagy, tumor microenvironment, cell metabolism, dormancy, nutraceutics, epigenetics, 3D models, personalized cancer therapy.

Natalie R. Gassman

Department of Physiology and Cell Biology, University of South Alabama College of Medicine, Mobile, AL, USA.

Research Interests: triple negative breast cancer, DNA damage, DNA repair, base excision repair.

Xin Hong

Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.

Research Interests: circulating tumor cells (CTCs), liquid biopsy, cancer metastasis, non-invasive biomarkers.

Sachi Horibata

Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.

Research Interests: cancer drug resistance, cancer biology, genomics, precision oncology.

Parvez Khan

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.

Research Interests: cancer biology, lung cancer, brain metastasis, chemotherapeutic resistance, cancer therapeutics, cancer metabolism, protein kinases, molecular biophysics, small molecule inhibitors, structure-based drug design and discovery.

Weiwen Long

Department of Biochemistry and Molecular Biology, Wright State University, Dayton, OH, USA.

Research Interests: growth factor signaling, steroid receptor/coactivator signaling, the interplay between these two signaling pathways in cancer progression and metastasis.

Elena Mariotto

Department of Woman’s and Child’s Health, University of Padova, Padova, Italy.

Research Interests: high throughput drug screening (HTS), medulloblastoma, acute lymphoblastic leukemia, pediatric cancer, cell cycle, apoptosis, kinase inhibitors.

Chiara Martinelli

Department of Chemistry, Materials and Chemical Engineering “Giulio Natta”, Politecnico di Milano, Milan, Italy.

Research Interests: cancer, theragnostics, targeted therapy, nanotechnology, nanomedicine, multifunctional nanomaterials, nanocarriers, drug delivery.

Hyllana C. D. Medeiros

Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA.

Research Interests: cancer metabolism, cancer therapy, chemo-resistant tumor models, drug resistance metabolism, cell death, reactive oxygen species, cancer cell signaling, mitochondrial-triggered cell death.

Faisal Raza

School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China.

Research Interests: cancer, targeted drug delivery, tumor microenvironment, cancer nanomedicine, biomimetic nanotechnology, biomaterials, drug resistance.

Giandomenico Roviello

Department of Health Sciences, University of Florence, Florence, Italy.

Research Interests: immunotherapy, prostate cancer, gastric cancer, renal cell carcinoma, chemotherapy.

Ravi P. Sahu

Department of Pharmacology and Toxicology, Boonshoft School of Medicine Wright State University, Dayton, OH, USA.

Research Interests: oxidative stressors and lipid mediators, cancer pharmacology and chemoprevention, anti-cancer agents and immunomodulation, cellular signaling pathways in tumor resistance mechanisms.

Iris Chiara Salaroglio

Department of Oncology, University of Turin, Turin, Italy.

Research Interests: MDR, oncology, chemoresistance, immunoresistance, drug response.

Ying Shen

Department of Pharmacology and Chemical Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Research Interests: molecular targeted therapy for lung cancer drug resistance, tumor metastasis, tumor pharmacology, tumor metabolism.

Quazi T. H. Shubhra

Wuhan Senstar Biotech, Wuhan, Hubei, China; Translational Medicine Engineering Research Center of Guangdong Province, Foshan, Guangdong, China.

Research Interests: nanotechnology, smart nanoparticles, targeted drug delivery, combination cancer therapy.

Santosh Singh

Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA, USA.

Research Interests: targeted therapy, nanotherapy, multidrug resistance, drug delivery, combination therapy, prostate cancer, breast cancer, ovarian cancer.

Abhishek Tyagi

Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

Research Interests: tumor microenvironment, cancer immunotherapy, breast and lung cancer, tumor metastasis, non-coding RNAs, cancer stem cells and radioresistance.

Jingya Wang

Department of Cancer Center, Houston Methodist, Houston, TX, USA.

Research Interests: myltiple myeloma, epigenetics, immunotherapy, cancer immunology, gamma delta T cells, CAR-T.

Ling Wang

School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.

Research Interests: computer-aided drug design, artificial intelligence-aided drug discovery and medicinal chemistry, the design and discovery of kinase inhibitors.

Cristina Xavier

Cancer Drug Resistance Group, i3S - Instituto de Investigação e Inovação em Saúde, IPATIMUP - Institute of Molecular Pathology and Immunology, University of Porto, Porto, Portugal.

Research Interests: drug discovery, pancreatic cancer, lung cancer, cancer drug resistance, cancer therapy, cancer biology, extracellular vesicles.

Yanlin Yu

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Research Interests: tumor metastasis, mouse models, tumor immunology, drug discovery, drug resistance, targeted therapy.

Giorgia Zadra

Institute of Molecular Genetics, National Research Council, Pavia, Italy.

Research Interests: prostate cancer, cancer metabolism, metabolic imaging, metabolomics, diet & lipid metabolism, cancer microenvironment, resistance to endocrine therapies, cancer progression.

Jianye Zhang

School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China.

Research Interests: tumor biology, novel technology application in cancer research, anticancer agents from natural products.

Wei Zhao

Key Laboratory of Stem Cells and Tissue Engineering, Sun Yat-Sen University, Guangzhou, China.

Research Interests: cancer epigenetics, histone modification and RNA methylation in cancers, single-cell analysis of tumor environment.

Xiangxuan Zhao

Department of Radiology, Shengjing Hospital of China Medical University, Liaoning, China.

Research Interests: natural products, cancer resistance, cancer biology, apoptosis, immunotherapy, exosomes, epigenetics.

Cancer Drug Resistance
ISSN 2578-532X (Online)
Follow Us


All published articles will preserved here permanently:


All published articles will preserved here permanently: